Global Cancer Diagnostics Market – Global Industry Analysis and Forecast (2018-2026) – By Product, By Application, and By Region.

Global Cancer Diagnostics Market – Global Industry Analysis and Forecast (2018-2026) – By Product, By Application, and By Region.

Market Scenario

Global Cancer Diagnostics Market was valued US$ 7.6 Bn in 2017 and is expected to reach US$ 19.36 Bn by 2026, at a CAGR of 12.4% during a forecast period. The cancer diagnostics market is segmented into product, application, and region. In terms of product, global cancer diagnostics market is classified into laboratory tests, genetic tests, imaging, endoscopy, biopsy, and others. Based on an application, global cancer diagnostics market is divided into breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, liver cancer, pancreatic cancer, ovarian cancer, and others. Based on regions, the global cancer diagnostics market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa. Global Cancer Diagnostics Market In terms of application, the largest market share for the cancer diagnostics market is breast cancer. Mammography played a key role in this market share, as it is the most commonly used screening test for breast cancer. The demand for liver & kidney cancer screening is anticipated to rise significantly in the near future due to the surging consumption of tobacco & alcohol is resulting in the increased prevalence of tumor in the liver and kidney. Based on products, the imaging segment is leading the market with the largest share in the market throughout the forecast period due to the imaging modalities such as computed tomography scan and magnetic resonance imaging are quick, non-invasive, and pain-free diagnostic solutions. These imaging modalities are used as supportive tests along with other laboratory and genetic tests to determine the location and severity of the condition in diagnosing a variety of cancer types. The laboratory tests include testing of blood, urine, other body fluids, or tissue for the presence of certain biomarkers, while genetic tests include detection of genetic aberrations in DNA and RNA samples taken from tumors. The rising awareness and supportive government initiatives are boosting the market growth. The growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are also propelling the market growth. Moreover, advancing technology is adding fuel to the growth of the market. Furthermore, the increasing prevalence of the different type of cancer drives market growth. The availability of expensive treatment and poor reimbursement policies are hampering the market growth during the forecast period. Geographically, North America is expected to dominate the vertical throughout the forecast period owing to factors such as greater funding available for research and development projects and high adoption of advanced technologies. North America dominated the market by capturing the largest revenue share of the market. Presence of numerous biotechnology as well as medical device companies in the region is one of the prime factors driving the growth of the diagnostics sector in the region. Key player operating in global cancer diagnostics market are Abbott Diagnostics, Agilent Technologies, Inc., Becton, Dickinson and Company, bioMerieux, C.R. Bard, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic, Inc., Illumina, Inc., and Koninkli.

Scope of Global Cancer Diagnostics Market:

Global Cancer Diagnostics Market, by Product:

• Laboratory Tests • Genetic Tests • Imaging • Endoscopy • Biopsy • Others

Global Cancer Diagnostics Market, by Application:

• Breast Cancer • Colorectal Cancer • Cervical Cancer • Lung Cancer • Prostate Cancer • Skin Cancer • Blood Cancer • Kidney Cancer • Liver Cancer • Pancreatic Cancer • Ovarian Cancer • Others

Global Cancer Diagnostics Market, by Region:

• North America • Europe • Asia Pacific • Latin America • Middle East & Africa

Key player operating in Global Cancer Diagnostics Market:

• Abbott Diagnostics • Agilent Technologies, Inc. • Becton, Dickinson and Company • bioMérieux • C.R. Bard, Inc. • F. Hoffmann-La Roche Ltd. • GE Healthcare (A Subsidiary of General Electric Company) • Hologic, Inc. • Illumina, Inc. • Koninkli Global Artificial Intelligence (AI) Healthcare Market

Table of Contents

Global Cancer Diagnostics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Cancer Diagnostics Market Size, by Market Value (US$ Bn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4. Global Cancer Diagnostics Market Industry Trends and Emerging Technologies 5. Global Cancer Diagnostics Market Analysis and Forecast 5.1. Global Cancer Diagnostics Market Analysis and Forecast 5.2. Global Cancer Diagnostics Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Cancer Diagnostics Market Analysis and Forecast, by Product 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Cancer Diagnostics Market Value Share Analysis, by Product 6.4. Global Cancer Diagnostics Market Size (US$ Bn) Forecast, by Product 6.5. Global Cancer Diagnostics Market Analysis, by Product 6.6. Global Cancer Diagnostics Market Attractiveness Analysis, by Product 7. Global Cancer Diagnostics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Cancer Diagnostics Market Value Share Analysis, by Application 7.3. Global Cancer Diagnostics Market Size (US$ Bn) Forecast, by Application 7.4. Global Cancer Diagnostics Market Analysis, by Application 7.5. Global Cancer Diagnostics Market Attractiveness Analysis, by Application 8. Global Cancer Diagnostics Market Analysis, by Region 8.1. Global Cancer Diagnostics Market Value Share Analysis, by Region 8.2. Global Cancer Diagnostics Market Size (US$ Bn) Forecast, by Region 8.3. Global Cancer Diagnostics Market Attractiveness Analysis, by Region 9. North America Cancer Diagnostics Market Analysis 9.1. Key Findings 9.2. North America Cancer Diagnostics Market Overview 9.3. North America Cancer Diagnostics Market Value Share Analysis, by Product 9.4. North America Cancer Diagnostics Market Forecast, by Product 9.4.1. Laboratory Tests 9.4.2. Genetic Tests 9.4.3. Imaging 9.4.4. Endoscopy 9.4.5. Biopsy 9.4.6. Others 9.5. North America Cancer Diagnostics Market Value Share Analysis, by Application 9.6. North America Cancer Diagnostics Market Forecast, by Application 9.6.1. Breast Cancer 9.6.2. Colorectal Cancer 9.6.3. Cervical Cancer 9.6.4. Lung Cancer 9.6.5. Prostate Cancer 9.6.6. Skin Cancer 9.6.7. Blood Cancer 9.6.8. Kidney Cancer 9.6.9. Liver Cancer 9.6.10. Pancreatic Cancer 9.6.11. Ovarian Cancer 9.6.12. Others 9.7. North America Cancer Diagnostics Market Value Share Analysis, by Country 9.8. North America Cancer Diagnostics Market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America Cancer Diagnostics Market Analysis, by Country 9.10. U.S. Cancer Diagnostics Market Forecast, by Product 9.10.1. Laboratory Tests 9.10.2. Genetic Tests 9.10.3. Imaging 9.10.4. Endoscopy 9.10.5. Biopsy 9.10.6. Others 9.11. U.S. Cancer Diagnostics Market Forecast, by Application 9.11.1. Breast Cancer 9.11.2. Colorectal Cancer 9.11.3. Cervical Cancer 9.11.4. Lung Cancer 9.11.5. Prostate Cancer 9.11.6. Skin Cancer 9.11.7. Blood Cancer 9.11.8. Kidney Cancer 9.11.9. Liver Cancer 9.11.10. Pancreatic Cancer 9.11.11. Ovarian Cancer 9.11.12. Others 9.12. Canada Cancer Diagnostics Market Forecast, by Product 9.12.1. Laboratory Tests 9.12.2. Genetic Tests 9.12.3. Imaging 9.12.4. Endoscopy 9.12.5. Biopsy 9.12.6. Others 9.13. Canada Cancer Diagnostics Market Forecast, by Application 9.13.1. Breast Cancer 9.13.2. Colorectal Cancer 9.13.3. Cervical Cancer 9.13.4. Lung Cancer 9.13.5. Prostate Cancer 9.13.6. Skin Cancer 9.13.7. Blood Cancer 9.13.8. Kidney Cancer 9.13.9. Liver Cancer 9.13.10. Pancreatic Cancer 9.13.11. Ovarian Cancer 9.13.12. Others 9.14. North America Cancer Diagnostics Market Attractiveness Analysis 9.14.1. By Product 9.14.2. By Application 9.15. PEST Analysis 10. Europe Cancer Diagnostics Market Analysis 10.1. Key Findings 10.2. Europe Cancer Diagnostics Market Overview 10.3. Europe Cancer Diagnostics Market Value Share Analysis, by Product 10.4. Europe Cancer Diagnostics Market Forecast, by Product 10.4.1. Laboratory Tests 10.4.2. Genetic Tests 10.4.3. Imaging 10.4.4. Endoscopy 10.4.5. Biopsy 10.4.6. Others 10.5. Europe Cancer Diagnostics Market Value Share Analysis, by Application 10.6. Europe Cancer Diagnostics Market Forecast, by Application 10.6.1. Breast Cancer 10.6.2. Colorectal Cancer 10.6.3. Cervical Cancer 10.6.4. Lung Cancer 10.6.5. Prostate Cancer 10.6.6. Skin Cancer 10.6.7. Blood Cancer 10.6.8. Kidney Cancer 10.6.9. Liver Cancer 10.6.10. Pancreatic Cancer 10.6.11. Ovarian Cancer 10.6.12. Others 10.7. Europe Cancer Diagnostics Market Value Share Analysis, by Country 10.8. Europe Cancer Diagnostics Market Forecast, by Country 10.8.1. Germany 10.8.2. U.K. 10.8.3. France 10.8.4. Italy 10.8.5. Spain 10.8.6. Rest of Europe 10.9. Europe Cancer Diagnostics Market Analysis, by Country/ Sub-region 10.10. Germany Cancer Diagnostics Market Forecast, by Product 10.10.1. Laboratory Tests 10.10.2. Genetic Tests 10.10.3. Imaging 10.10.4. Endoscopy 10.10.5. Biopsy 10.10.6. Others 10.11. Germany Cancer Diagnostics Market Forecast, by Application 10.11.1. Breast Cancer 10.11.2. Colorectal Cancer 10.11.3. Cervical Cancer 10.11.4. Lung Cancer 10.11.5. Prostate Cancer 10.11.6. Skin Cancer 10.11.7. Blood Cancer 10.11.8. Kidney Cancer 10.11.9. Liver Cancer 10.11.10. Pancreatic Cancer 10.11.11. Ovarian Cancer 10.11.12. Others 10.12. U.K. Cancer Diagnostics Market Forecast, by Product 10.12.1. Laboratory Tests 10.12.2. Genetic Tests 10.12.3. Imaging 10.12.4. Endoscopy 10.12.5. Biopsy 10.12.6. Others 10.13. U.K. Cancer Diagnostics Market Forecast, by Application 10.13.1. Breast Cancer 10.13.2. Colorectal Cancer 10.13.3. Cervical Cancer 10.13.4. Lung Cancer 10.13.5. Prostate Cancer 10.13.6. Skin Cancer 10.13.7. Blood Cancer 10.13.8. Kidney Cancer 10.13.9. Liver Cancer 10.13.10. Pancreatic Cancer 10.13.11. Ovarian Cancer 10.13.12. Others 10.14. France Cancer Diagnostics Market Forecast, by Product 10.14.1. Laboratory Tests 10.14.2. Genetic Tests 10.14.3. Imaging 10.14.4. Endoscopy 10.14.5. Biopsy 10.14.6. Others 10.15. France Cancer Diagnostics Market Forecast, by Application 10.15.1. Breast Cancer 10.15.2. Colorectal Cancer 10.15.3. Cervical Cancer 10.15.4. Lung Cancer 10.15.5. Prostate Cancer 10.15.6. Skin Cancer 10.15.7. Blood Cancer 10.15.8. Kidney Cancer 10.15.9. Liver Cancer 10.15.10. Pancreatic Cancer 10.15.11. Ovarian Cancer 10.15.12. Others 10.16. Italy Cancer Diagnostics Market Forecast, by Product 10.16.1. Laboratory Tests 10.16.2. Genetic Tests 10.16.3. Imaging 10.16.4. Endoscopy 10.16.5. Biopsy 10.16.6. Others 10.17. Italy Cancer Diagnostics Market Forecast, by Application 10.17.1. Breast Cancer 10.17.2. Colorectal Cancer 10.17.3. Cervical Cancer 10.17.4. Lung Cancer 10.17.5. Prostate Cancer 10.17.6. Skin Cancer 10.17.7. Blood Cancer 10.17.8. Kidney Cancer 10.17.9. Liver Cancer 10.17.10. Pancreatic Cancer 10.17.11. Ovarian Cancer 10.17.12. Others 10.18. Spain Cancer Diagnostics Market Forecast, by Product 10.18.1. Laboratory Tests 10.18.2. Genetic Tests 10.18.3. Imaging 10.18.4. Endoscopy 10.18.5. Biopsy 10.18.6. Others 10.19. Spain Cancer Diagnostics Market Forecast, by Application 10.19.1. Breast Cancer 10.19.2. Colorectal Cancer 10.19.3. Cervical Cancer 10.19.4. Lung Cancer 10.19.5. Prostate Cancer 10.19.6. Skin Cancer 10.19.7. Blood Cancer 10.19.8. Kidney Cancer 10.19.9. Liver Cancer 10.19.10. Pancreatic Cancer 10.19.11. Ovarian Cancer 10.19.12. Others 10.20. Rest of Europe Cancer Diagnostics Market Forecast, by Product 10.20.1. Laboratory Tests 10.20.2. Genetic Tests 10.20.3. Imaging 10.20.4. Endoscopy 10.20.5. Biopsy 10.20.6. Others 10.21. Rest of Europe Cancer Diagnostics Market Forecast, by Application 10.21.1. Breast Cancer 10.21.2. Colorectal Cancer 10.21.3. Cervical Cancer 10.21.4. Lung Cancer 10.21.5. Prostate Cancer 10.21.6. Skin Cancer 10.21.7. Blood Cancer 10.21.8. Kidney Cancer 10.21.9. Liver Cancer 10.21.10. Pancreatic Cancer 10.21.11. Ovarian Cancer 10.21.12. Others 10.22. Europe Cancer Diagnostics Market Attractiveness Analysis 10.22.1. By Product 10.22.2. By Application 10.23. PEST Analysis 11. Asia Pacific Cancer Diagnostics Market Analysis 11.1. Key Findings 11.2. Asia Pacific Cancer Diagnostics Market Overview 11.3. Asia Pacific Cancer Diagnostics Market Value Share Analysis, by Product 11.4. Asia Pacific Cancer Diagnostics Market Forecast, by Product 11.4.1. Laboratory Tests 11.4.2. Genetic Tests 11.4.3. Imaging 11.4.4. Endoscopy 11.4.5. Biopsy 11.4.6. Others 11.5. Asia Pacific Cancer Diagnostics Market Value Share Analysis, by Application 11.6. Asia Pacific Cancer Diagnostics Market Forecast, by Application 11.6.1. Breast Cancer 11.6.2. Colorectal Cancer 11.6.3. Cervical Cancer 11.6.4. Lung Cancer 11.6.5. Prostate Cancer 11.6.6. Skin Cancer 11.6.7. Blood Cancer 11.6.8. Kidney Cancer 11.6.9. Liver Cancer 11.6.10. Pancreatic Cancer 11.6.11. Ovarian Cancer 11.6.12. Others 11.7. Asia Pacific Cancer Diagnostics Market Value Share Analysis, by Country 11.8. Asia Pacific Cancer Diagnostics Market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific Cancer Diagnostics Market Analysis, by Country/ Sub-region 11.10. China Cancer Diagnostics Market Forecast, by Product 11.10.1. Laboratory Tests 11.10.2. Genetic Tests 11.10.3. Imaging 11.10.4. Endoscopy 11.10.5. Biopsy 11.10.6. Others 11.11. China Cancer Diagnostics Market Forecast, by Application 11.11.1. Breast Cancer 11.11.2. Colorectal Cancer 11.11.3. Cervical Cancer 11.11.4. Lung Cancer 11.11.5. Prostate Cancer 11.11.6. Skin Cancer 11.11.7. Blood Cancer 11.11.8. Kidney Cancer 11.11.9. Liver Cancer 11.11.10. Pancreatic Cancer 11.11.11. Ovarian Cancer 11.11.12. Others 11.12. India Cancer Diagnostics Market Forecast, by Product 11.12.1. Laboratory Tests 11.12.2. Genetic Tests 11.12.3. Imaging 11.12.4. Endoscopy 11.12.5. Biopsy 11.12.6. Others 11.13. India Cancer Diagnostics Market Forecast, by Application 11.13.1. Breast Cancer 11.13.2. Colorectal Cancer 11.13.3. Cervical Cancer 11.13.4. Lung Cancer 11.13.5. Prostate Cancer 11.13.6. Skin Cancer 11.13.7. Blood Cancer 11.13.8. Kidney Cancer 11.13.9. Liver Cancer 11.13.10. Pancreatic Cancer 11.13.11. Ovarian Cancer 11.13.12. Others 11.14. Japan Cancer Diagnostics Market Forecast, by Product 11.14.1. Laboratory Tests 11.14.2. Genetic Tests 11.14.3. Imaging 11.14.4. Endoscopy 11.14.5. Biopsy 11.14.6. Others 11.15. Japan Cancer Diagnostics Market Forecast, by Application 11.15.1. Breast Cancer 11.15.2. Colorectal Cancer 11.15.3. Cervical Cancer 11.15.4. Lung Cancer 11.15.5. Prostate Cancer 11.15.6. Skin Cancer 11.15.7. Blood Cancer 11.15.8. Kidney Cancer 11.15.9. Liver Cancer 11.15.10. Pancreatic Cancer 11.15.11. Ovarian Cancer 11.15.12. Others 11.16. ASEAN Cancer Diagnostics Market Forecast, by Product 11.16.1. Laboratory Tests 11.16.2. Genetic Tests 11.16.3. Imaging 11.16.4. Endoscopy 11.16.5. Biopsy 11.16.6. Others 11.17. ASEAN Cancer Diagnostics Market Forecast, by Application 11.17.1. Breast Cancer 11.17.2. Colorectal Cancer 11.17.3. Cervical Cancer 11.17.4. Lung Cancer 11.17.5. Prostate Cancer 11.17.6. Skin Cancer 11.17.7. Blood Cancer 11.17.8. Kidney Cancer 11.17.9. Liver Cancer 11.17.10. Pancreatic Cancer 11.17.11. Ovarian Cancer 11.17.12. Others 11.18. Rest of Asia Pacific Cancer Diagnostics Market Forecast, by Product 11.18.1. Laboratory Tests 11.18.2. Genetic Tests 11.18.3. Imaging 11.18.4. Endoscopy 11.18.5. Biopsy 11.18.6. Others 11.19. Rest of Asia Pacific Cancer Diagnostics Market Forecast, by Application 11.19.1. Breast Cancer 11.19.2. Colorectal Cancer 11.19.3. Cervical Cancer 11.19.4. Lung Cancer 11.19.5. Prostate Cancer 11.19.6. Skin Cancer 11.19.7. Blood Cancer 11.19.8. Kidney Cancer 11.19.9. Liver Cancer 11.19.10. Pancreatic Cancer 11.19.11. Ovarian Cancer 11.19.12. Others 11.20. Asia Pacific Cancer Diagnostics Market Attractiveness Analysis 11.20.1. By Product 11.20.2. By Application 11.21. PEST Analysis 12. Middle East & Africa Cancer Diagnostics Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Cancer Diagnostics Market Overview 12.3. Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by Product 12.4. Middle East & Africa Cancer Diagnostics Market Forecast, by Product 12.4.1. Laboratory Tests 12.4.2. Genetic Tests 12.4.3. Imaging 12.4.4. Endoscopy 12.4.5. Biopsy 12.4.6. Others 12.5. Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by Application 12.6. Middle East & Africa Cancer Diagnostics Market Forecast, by Application 12.6.1. Breast Cancer 12.6.2. Colorectal Cancer 12.6.3. Cervical Cancer 12.6.4. Lung Cancer 12.6.5. Prostate Cancer 12.6.6. Skin Cancer 12.6.7. Blood Cancer 12.6.8. Kidney Cancer 12.6.9. Liver Cancer 12.6.10. Pancreatic Cancer 12.6.11. Ovarian Cancer 12.6.12. Others 12.7. Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by Country 12.8. Middle East & Africa Cancer Diagnostics Market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa Cancer Diagnostics Market Analysis, by Country/ Sub-region 12.10. GCC Cancer Diagnostics Market Forecast, by Product 12.10.1. Laboratory Tests 12.10.2. Genetic Tests 12.10.3. Imaging 12.10.4. Endoscopy 12.10.5. Biopsy 12.10.6. Others 12.11. GCC Cancer Diagnostics Market Forecast, by Application 12.11.1. Breast Cancer 12.11.2. Colorectal Cancer 12.11.3. Cervical Cancer 12.11.4. Lung Cancer 12.11.5. Prostate Cancer 12.11.6. Skin Cancer 12.11.7. Blood Cancer 12.11.8. Kidney Cancer 12.11.9. Liver Cancer 12.11.10. Pancreatic Cancer 12.11.11. Ovarian Cancer 12.11.12. Others 12.12. South Africa Cancer Diagnostics Market Forecast, by Product 12.12.1. Laboratory Tests 12.12.2. Genetic Tests 12.12.3. Imaging 12.12.4. Endoscopy 12.12.5. Biopsy 12.12.6. Others 12.13. South Africa Cancer Diagnostics Market Forecast, by Application 12.13.1. Breast Cancer 12.13.2. Colorectal Cancer 12.13.3. Cervical Cancer 12.13.4. Lung Cancer 12.13.5. Prostate Cancer 12.13.6. Skin Cancer 12.13.7. Blood Cancer 12.13.8. Kidney Cancer 12.13.9. Liver Cancer 12.13.10. Pancreatic Cancer 12.13.11. Ovarian Cancer 12.13.12. Others 12.14. Rest of Middle East & Africa Cancer Diagnostics Market Forecast, by Product 12.14.1. Laboratory Tests 12.14.2. Genetic Tests 12.14.3. Imaging 12.14.4. Endoscopy 12.14.5. Biopsy 12.14.6. Others 12.15. Rest of Middle East & Africa Cancer Diagnostics Market Forecast, by Application 12.15.1. Breast Cancer 12.15.2. Colorectal Cancer 12.15.3. Cervical Cancer 12.15.4. Lung Cancer 12.15.5. Prostate Cancer 12.15.6. Skin Cancer 12.15.7. Blood Cancer 12.15.8. Kidney Cancer 12.15.9. Liver Cancer 12.15.10. Pancreatic Cancer 12.15.11. Ovarian Cancer 12.15.12. Others 12.16. Middle East & Africa Cancer Diagnostics Market Attractiveness Analysis 12.16.1. By Product 12.16.2. By Application 12.17. PEST Analysis 13. Latin America Cancer Diagnostics Market Analysis 13.1. Key Findings 13.2. Latin America Cancer Diagnostics Market Overview 13.3. Latin America Cancer Diagnostics Market Value Share Analysis, by Product 13.4. Latin America Cancer Diagnostics Market Forecast, by Product 13.4.1. Laboratory Tests 13.4.2. Genetic Tests 13.4.3. Imaging 13.4.4. Endoscopy 13.4.5. Biopsy 13.4.6. Others 13.5. Latin America Cancer Diagnostics Market Value Share Analysis, by Application 13.6. Latin America Cancer Diagnostics Market Forecast, by Application 13.6.1. Breast Cancer 13.6.2. Colorectal Cancer 13.6.3. Cervical Cancer 13.6.4. Lung Cancer 13.6.5. Prostate Cancer 13.6.6. Skin Cancer 13.6.7. Blood Cancer 13.6.8. Kidney Cancer 13.6.9. Liver Cancer 13.6.10. Pancreatic Cancer 13.6.11. Ovarian Cancer 13.6.12. Others 13.7. Latin America Cancer Diagnostics Market Value Share Analysis, by Country 13.8. Latin America Cancer Diagnostics Market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of Latin America 13.9. Latin America Cancer Diagnostics Market Analysis, by Country/ Sub-region 13.10. Brazil Cancer Diagnostics Market Forecast, by Product 13.10.1. Laboratory Tests 13.10.2. Genetic Tests 13.10.3. Imaging 13.10.4. Endoscopy 13.10.5. Biopsy 13.10.6. Others 13.11. Brazil Cancer Diagnostics Market Forecast, by Application 13.11.1. Breast Cancer 13.11.2. Colorectal Cancer 13.11.3. Cervical Cancer 13.11.4. Lung Cancer 13.11.5. Prostate Cancer 13.11.6. Skin Cancer 13.11.7. Blood Cancer 13.11.8. Kidney Cancer 13.11.9. Liver Cancer 13.11.10. Pancreatic Cancer 13.11.11. Ovarian Cancer 13.11.12. Others 13.12. Mexico Cancer Diagnostics Market Forecast, by Product 13.12.1. Laboratory Tests 13.12.2. Genetic Tests 13.12.3. Imaging 13.12.4. Endoscopy 13.12.5. Biopsy 13.12.6. Others 13.13. Mexico Cancer Diagnostics Market Forecast, by Application 13.13.1. Breast Cancer 13.13.2. Colorectal Cancer 13.13.3. Cervical Cancer 13.13.4. Lung Cancer 13.13.5. Prostate Cancer 13.13.6. Skin Cancer 13.13.7. Blood Cancer 13.13.8. Kidney Cancer 13.13.9. Liver Cancer 13.13.10. Pancreatic Cancer 13.13.11. Ovarian Cancer 13.13.12. Others 13.14. Rest of Latin America Cancer Diagnostics Market Forecast, by Product 13.14.1. Laboratory Tests 13.14.2. Genetic Tests 13.14.3. Imaging 13.14.4. Endoscopy 13.14.5. Biopsy 13.14.6. Others 13.15. Rest of Latin America Cancer Diagnostics Market Forecast, by Application 13.15.1. Breast Cancer 13.15.2. Colorectal Cancer 13.15.3. Cervical Cancer 13.15.4. Lung Cancer 13.15.5. Prostate Cancer 13.15.6. Skin Cancer 13.15.7. Blood Cancer 13.15.8. Kidney Cancer 13.15.9. Liver Cancer 13.15.10. Pancreatic Cancer 13.15.11. Ovarian Cancer 13.15.12. Others 13.16. Latin America Cancer Diagnostics Market Attractiveness Analysis 13.16.1. By Product 13.16.2. By Application 13.17. PEST Analysis 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Company Profiles: Key Players 14.3.1. Koninkli 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Business Strategy 14.3.1.4. Recent Developments 14.3.1.5. Manufacturing Footprint 14.3.2. Abbott Diagnostics 14.3.3. Agilent Technologies, Inc. 14.3.4. Becton, Dickinson and Company 14.3.5. bioMérieux 14.3.6. C.R. Bard, Inc. 14.3.7. F. Hoffmann-La Roche Ltd. 14.3.8. GE Healthcare (A Subsidiary of General Electric Company) 14.3.9. Hologic, Inc. 14.3.10. Illumina, Inc. 15. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID21307
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now